Allscripts Healthcare Stock
Your prediction
Allscripts Healthcare Stock
There is no change in the price for Allscripts Healthcare today.
Pros and Cons of Allscripts Healthcare in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allscripts Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allscripts Healthcare | 0.000% | 5.882% | 5.882% | -57.647% | -57.647% | -78.049% | -68.142% |
| MicroVision Inc | 3.990% | -6.439% | -4.218% | -11.268% | -49.297% | -68.089% | -81.005% |
| Fonar Corp. New | 3.310% | -2.419% | -1.626% | -16.552% | -14.789% | -25.767% | -19.333% |
| Fluidigm Corp. | 6.920% | 4.839% | 27.451% | -41.964% | -23.977% | 13.142% | -76.303% |
Comments
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at TD Cowen from $26.00 to $15.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat
Veradigm Inc. (NASDAQ: MDRX) had its price target lowered by analysts at Royal Bank of Canada from $22.00 to $11.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MDRX provided by MarketBeat